JP2019535754A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019535754A5 JP2019535754A5 JP2019527426A JP2019527426A JP2019535754A5 JP 2019535754 A5 JP2019535754 A5 JP 2019535754A5 JP 2019527426 A JP2019527426 A JP 2019527426A JP 2019527426 A JP2019527426 A JP 2019527426A JP 2019535754 A5 JP2019535754 A5 JP 2019535754A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound according
- compound
- pharmaceutically acceptable
- equation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(CCC(*(*)*)C(*(*)C(CCCC*(*)C(CCCc1ccc(*)cc1)=O)O)=O)=O Chemical compound CC(CCC(*(*)*)C(*(*)C(CCCC*(*)C(CCCc1ccc(*)cc1)=O)O)=O)=O 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662425810P | 2016-11-23 | 2016-11-23 | |
| US62/425,810 | 2016-11-23 | ||
| PCT/US2017/063182 WO2018098390A1 (en) | 2016-11-23 | 2017-11-24 | Albumin-binding psma inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019535754A JP2019535754A (ja) | 2019-12-12 |
| JP2019535754A5 true JP2019535754A5 (enExample) | 2021-01-07 |
| JP7167021B2 JP7167021B2 (ja) | 2022-11-08 |
Family
ID=60812130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019527426A Active JP7167021B2 (ja) | 2016-11-23 | 2017-11-24 | アルブミン結合ｐｓｍａ阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11147889B2 (enExample) |
| EP (1) | EP3544960A1 (enExample) |
| JP (1) | JP7167021B2 (enExample) |
| CN (1) | CN109982998A (enExample) |
| BR (1) | BR112019010206A2 (enExample) |
| CA (1) | CA3043619A1 (enExample) |
| MX (1) | MX2019005742A (enExample) |
| WO (1) | WO2018098390A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102884167B1 (ko) * | 2017-10-22 | 2025-11-12 | 프로빈셜 헬스 서비시즈 오쏘리티 | 전립선 특이적 막 항원-발현 암의 진단 또는 치료를 위한 신규한 라디오메탈-결합 화합물 |
| US20210276971A1 (en) * | 2018-06-20 | 2021-09-09 | The Research Foundation For The State University Of New York | Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same |
| EP3880253A1 (en) * | 2018-11-14 | 2021-09-22 | Noria Therapeutics, Inc. | Thioamide-containing compositions and methods of use thereof |
| WO2020108753A1 (en) * | 2018-11-28 | 2020-06-04 | ITM Isotopen Technologien München AG | Novel tumor antigen binding agents and uses thereof |
| CA3136979A1 (en) | 2019-04-17 | 2020-10-22 | Provincial Health Services Authority | Radiolabelled compounds for diagnosis or treatment of prostate-spe cific membrane antigen-expressing cancer |
| CN119431260A (zh) | 2019-06-21 | 2025-02-14 | 省卫生服务机构 | 靶向前列腺特异性膜抗原的放射性标记化合物 |
| CN115210240A (zh) | 2020-03-04 | 2022-10-18 | 日本医事物理股份有限公司 | 化合物及放射性标记化合物 |
| KR20230027004A (ko) * | 2020-05-06 | 2023-02-27 | 코넬 유니버시티 | 구리-함유 테라그노스틱 화합물 및 사용 방법 |
| KR20230117581A (ko) * | 2020-12-04 | 2023-08-08 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 펩티드 수용체 방사성 핵종 요법 |
| WO2022126275A1 (en) * | 2020-12-16 | 2022-06-23 | The University Of British Columbia | Radiolabeled compounds targeting the prostate-specific membrane antigen |
| CN114685599A (zh) * | 2020-12-30 | 2022-07-01 | 南京江原安迪科正电子研究发展有限公司 | 一种psma靶向抑制剂及放射性核素标记的psma靶向抑制剂、制备方法和用途 |
| WO2022186311A1 (ja) * | 2021-03-04 | 2022-09-09 | 日本メジフィジックス株式会社 | 化合物及び放射性標識化合物 |
| EP4486756A1 (en) * | 2022-03-04 | 2025-01-08 | Provincial Health Services Authority | Radiolabeled compounds targeting the prostate-specific membrane antigen |
| WO2024126687A1 (en) * | 2022-12-16 | 2024-06-20 | Silence Therapeutics Gmbh | Nucleic acids conjugated to an albumin binding moiety |
| KR20250148672A (ko) * | 2023-02-16 | 2025-10-14 | 노로이 바이오사이언스 씨오., 엘티디. | Psma 표적 방사성 약물 및 그 합성과 응용 |
| CN116217505B (zh) * | 2023-03-17 | 2024-10-01 | 南京医科大学 | 用于诊断或治疗表达前列腺特异性膜抗原癌症的新型标记靶向剂 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0621973D0 (en) * | 2006-11-03 | 2006-12-13 | Philogen Spa | Binding molecules and uses thereof |
| CA3131469A1 (en) * | 2009-03-19 | 2010-09-23 | The Johns Hopkins University | Psma-targeting compounds and uses thereof |
| HUE045028T2 (hu) | 2011-08-05 | 2019-12-30 | Molecular Insight Pharm Inc | Radiojelzett prosztataspecifikus membrán antigén inhibitorok |
| WO2013028664A1 (en) * | 2011-08-22 | 2013-02-28 | Siemens Medical Solutions Usa, Inc. | Psma imaging agents |
| WO2015069932A1 (en) * | 2013-11-06 | 2015-05-14 | Solstice Biologics, Ltd. | Polynucleotide constructs having disulfide groups |
| EP3069147A4 (en) * | 2013-11-14 | 2017-10-11 | Endocyte, Inc. | Compounds for positron emission tomography |
| WO2016030329A1 (en) * | 2014-08-24 | 2016-03-03 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer |
| GEP20207106B (en) * | 2015-09-30 | 2020-05-11 | Deutsches Krebsforsch | 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer |
| KR20250057132A (ko) * | 2016-03-22 | 2025-04-28 | 더 존스 홉킨스 유니버시티 | 전립선 암의 내부방사선요법을 위한 전립선-특이적 막 항원 표적화된 고-친화성 제제 |
| EP3474903B1 (en) * | 2016-06-23 | 2025-01-22 | Cornell University | Double targeted constructs to affect tumor kill |
| DE102016122273B4 (de) * | 2016-11-18 | 2018-06-21 | Abx Advanced Biochemical Compounds Gmbh | Präkursoren für die Radiofluorierung |
-
2017
- 2017-11-24 BR BR112019010206A patent/BR112019010206A2/pt not_active Application Discontinuation
- 2017-11-24 WO PCT/US2017/063182 patent/WO2018098390A1/en not_active Ceased
- 2017-11-24 MX MX2019005742A patent/MX2019005742A/es unknown
- 2017-11-24 CN CN201780071927.6A patent/CN109982998A/zh active Pending
- 2017-11-24 JP JP2019527426A patent/JP7167021B2/ja active Active
- 2017-11-24 EP EP17821755.0A patent/EP3544960A1/en not_active Withdrawn
- 2017-11-24 US US16/349,756 patent/US11147889B2/en active Active
- 2017-11-24 CA CA3043619A patent/CA3043619A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019535754A5 (enExample) | ||
| CN101668547B (zh) | 选择缺氧组织的弱碱性2-硝基咪唑递送剂及其应用方法 | |
| US8435489B2 (en) | Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma | |
| US11147889B2 (en) | Albumin-binding PSMA inhibitors | |
| JP2014510729A5 (enExample) | ||
| JP2006501149A5 (enExample) | ||
| JP2006524250A5 (enExample) | ||
| JP2010523599A5 (enExample) | ||
| WO2008124651A3 (en) | Nitro-imidazole hypoxia imaging agents | |
| JP2010524965A5 (enExample) | ||
| CA3030907A1 (en) | Chelated psma inhibitors | |
| DE602004017290D1 (de) | Konjugate für medizinische abbildungen umfassend träger, targeting-anteile und kontrastmittel | |
| JP2015528814A5 (enExample) | ||
| JP2016528299A5 (enExample) | ||
| JP2012504131A5 (enExample) | ||
| CA2722858C (en) | Substrate based pet imaging agents | |
| CN111447955A (zh) | 99mTc-替马诺塞和相关的分子构建体用于鉴定和诊断恶性肿瘤和用于监测治疗性抗肿瘤干预的用途 | |
| JP2025165975A5 (enExample) | ||
| JP2013504590A5 (enExample) | ||
| JP2009538894A5 (enExample) | ||
| Das et al. | 177Lu-DOTMP: a viable agent for palliative radiotherapy of painful bone metastasis | |
| Subbarayan et al. | Evaluation studies of technetium-99m-porphyrin (T3, 4BCPP) for tumor imaging | |
| Welch et al. | Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides | |
| JP2024542261A (ja) | 診療に寄与する新規ホウ素リポソーム | |
| JP6263716B2 (ja) | 悪性腫瘍のｐｅｔ診断用トレーサー |